The basis of membrane stabilized effect of kopaxon in multiple sclerosis
We have studied the influence of kopaxon on the structure of lipid phase of cellular membranes of red corpuscles, the condition of process of peroxide lipids oxidation and the system of antioxidative defence of 58 people with remittent form of multiple sclerosis. On the grounds of analysis of dynami...
Main Authors: | L. I. Reikhert, O. A. Kicherova, A. A. Sokolova, Zsh. I. Molchanova |
---|---|
Format: | Article |
Language: | English |
Published: |
Siberian State Medical University (Tomsk)
2009-02-01
|
Series: | Бюллетень сибирской медицины |
Subjects: | |
Online Access: | https://bulletin.ssmu.ru/jour/article/view/1767 |
Similar Items
-
Copaxone in therapy of remittent disseminated sclerosis patients
by: O. A. Kitcherova, et al.
Published: (2008-09-01) -
RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
by: F. A. Khabirov, et al.
Published: (2017-01-01) -
Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
by: I. V. Smagina, et al.
Published: (2010-08-01) -
PREVALENCE AND SEVERITY OF HYPOVITAMINOSIS D IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE SVERDLOVSK REGION
by: E L Turova, et al.
Published: (2012-12-01) -
Multiple sclerosis prevalence and risk factors among the Altai Region population
by: I. V. Smagina, et al.
Published: (2011-04-01)